Mirae Asset Global Investments
CRNX icon

Mirae Asset Global Investments’s Crinetics Pharmaceuticals CRNX Stock Holding History

Mirae Asset Global Investments’s Portfolio CRNX Stock Details CRNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$176K Sell
4,716
-745
-14% -$27.7K ﹤0.01% 1143
2026
Q1 		$198K Buy
5,461
+850
+18% +$38K ﹤0.01% 1072
2025
Q4 		$215K Buy
4,611
+970
+27% +$43.2K ﹤0.01% 1135
2025
Q3 		$152K Buy
3,641
+22
+0.6% +$703 ﹤0.01% 1154
2025
Q2 		$104K Buy
3,619
+505
+16% +$15.6K ﹤0.01% 1132
2025
Q1 		$108K Buy
3,114
+24
+0.8% +$896 ﹤0.01% 1117
2024
Q4 		$160K Buy
3,090
+195
+7% +$10.9K ﹤0.01% 1079
2024
Q3 		$147K Buy
2,895
+541
+23% +$27.9K ﹤0.01% 1138
2024
Q2 		$102K Sell
2,354
-30,171
-93% -$1.39M ﹤0.01% 1139
2024
Q1 		$769K Sell
32,525
-6,693
-17% -$262K ﹤0.01% 1678
2023
Q4 		$1.4M Buy
39,218
+2,343
+6% +$71.8K ﹤0.01% 1441
2023
Q3 		$1.1M Buy
36,875
+7,021
+24% +$145K ﹤0.01% 1479
2023
Q2 		$537K Sell
29,854
-256
-0.9% -$5.11K ﹤0.01% 1915
2023
Q1 		$484K Buy
30,110
+4,841
+19% +$89.6K ﹤0.01% 1945
2022
Q4 		$462K Buy
25,269
+1,833
+8% +$32.3K ﹤0.01% 1933
2022
Q3 		$460K Buy
23,436
+8,167
+53% +$167K ﹤0.01% 1917
2022
Q2 		$284K Buy
+15,269
New +$305K ﹤0.01% 2015

Other funds holding CRNX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Universal-Beteiligungs- und Servicegesellschaft
Universal-Beteiligungs- und Servicegesellschaft Frankfurt Am Main, Germany $65.4B AUM 39.83% 1-Year Est. Return
BSA
Braun Stacey Associates New York $3.53B AUM 63.32% 1-Year Est. Return
Fiera Capital (Canada)
Fiera Capital (Canada) Montreal, Quebec, Canada $27.6B AUM 23.56% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return

Mirae Asset Global Investments's CRNX Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Crinetics Pharmaceuticals (CRNX) stake by 14% in Q2 2026, selling an estimated $27.7K and leaving 4,716 shares worth $176K. The position accounts for ﹤0.01% of the portfolio, ranked #1143.

Mirae Asset Global Investments first reported a position in CRNX in Q2 2022 and has held it in 17 quarters since. The position peaked at $1.4M in Q4 2023. 100 funds tracked by Wall St. Rank hold CRNX as of Q2 2026.

  • Mirae Asset Global Investments held 4,716 shares of Crinetics Pharmaceuticals worth $176K as of Q2 2026.
  • Mirae Asset Global Investments sold 745 Crinetics Pharmaceuticals shares in Q2 2026, an estimated $27.7K.
  • Crinetics Pharmaceuticals made up ﹤0.01% of Mirae Asset Global Investments's portfolio in Q2 2026, its #1143 holding.
  • Mirae Asset Global Investments first reported a position in Crinetics Pharmaceuticals in Q2 2022 and has held it in 17 quarters since.
  • Mirae Asset Global Investments's Crinetics Pharmaceuticals position peaked at $1.4M in Q4 2023.
  • 100 funds tracked by Wall St. Rank held Crinetics Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.